During the past decade, A.ö. Landeskrankenhaus Leoben conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "A.ö. Landeskrankenhaus Leoben" #1 collaborator was "Hoffmann-La Roche" with 4 trials as a collaborator, "Sanofi" with 3 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Cephalon" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "A.ö. Landeskrankenhaus Leoben" are "Breast Cancer" (3 trials), "B-cell Chronic Lymphocytic Leukemia" (1 trials), "Colon Cancer Stage II" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials) and "Diffuse Large B-Cell Lymphoma (DLBCL)" (1 trials). Many other conditions were trialed in "A.ö. Landeskrankenhaus Leoben" in a lesser frequency.

Most popular intervention types in "A.ö. Landeskrankenhaus Leoben" are "Drug" (11 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alemtuzumab" (2 trials), "Capecitabine" (2 trials), "Cetuximab" (2 trials), "Rituximab" (2 trials) and "5-FU" (1 trials). Other intervention names were less common.

The vast majority of trials in "A.ö. Landeskrankenhaus Leoben" are 9 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "A.ö. Landeskrankenhaus Leoben". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in A.ö. Landeskrankenhaus Leoben, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in A.ö. Landeskrankenhaus Leoben, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".